
<http://bio2rdf.org/drugbank:DB00085> a <http://schema.org/Drug> ;
	<http://schema.org/name> "Pancrelipase" ;
	<http://schema.org/description> "Pancrelipase is an enzyme mixture isolated from porcine or bovine pancreas, sometimes called pancreatin. It contains 3 enzymes: amylase, lipase, and a protease (chymotrypsin). Pancrelipase is marketed under several brand names such as Ultresa™ and Viokace™." ;
	<http://schema.org/drugClass> "Gastrointestinal Agents" , "Enzyme Replacement Agents" ;
	<http://schema.org/url> "http://bio2rdf.org/drugbank:DB00085" ;
	<http://schema.org/administrationRoute> "epidural; infiltration" , "oral" ;
	<http://schema.org/availableStrength> <http://bio2rdf.org/drugbank_resource:f70279cb9494a9eda450c00b55d0352f> , <http://bio2rdf.org/drugbank_resource:9a3b4abb8f273fa2f383b551a1894f0f> , <http://bio2rdf.org/drugbank_resource:27136092f71ea2dc0884122e1d472f2b> , <http://bio2rdf.org/drugbank_resource:1260467275068ce542e5c299b586399c> , <http://bio2rdf.org/drugbank_resource:b36bd6c496a004338641872653e73c55> , <http://bio2rdf.org/drugbank_resource:b249bfa106599ab2ea815c0538721b01> , <http://bio2rdf.org/drugbank_resource:175732483eb5d0afdce1e0b87ee0ae6f> , <http://bio2rdf.org/drugbank_resource:d7b4a2cd91ffa76e6ced42d860f720e6> , <http://bio2rdf.org/drugbank_resource:ba17e8c73ecc076468a27be60bd51000> , <http://bio2rdf.org/drugbank_resource:ac19273ac22375d315e23710d2b5cc80> , <http://bio2rdf.org/drugbank_resource:d9ffd5f12f88be5848c77072a4dc4885> , <http://bio2rdf.org/drugbank_resource:bfa1b3202d38637a18d8bcfd8c3e23e1> , <http://bio2rdf.org/drugbank_resource:5ec480f1898bc210cd4f4f879582cacb> , <http://bio2rdf.org/drugbank_resource:5ebc91afa2630a7ae33f0c165c59a6e5> , <http://bio2rdf.org/drugbank_resource:c78b0a07c1f0add4a6a69d96c1a51410> , <http://bio2rdf.org/drugbank_resource:e683fe8ebafdf4d83c824776e4144db6> , <http://bio2rdf.org/drugbank_resource:06b122a4103620abd546ff8709085515> , <http://bio2rdf.org/drugbank_resource:e42f8d5be9f3d3dd82e7435e76128245> , <http://bio2rdf.org/drugbank_resource:8532faf6b74a0718755250462da33523> , <http://bio2rdf.org/drugbank_resource:03e8c102c79db06eecd326f99a3b3942> , <http://bio2rdf.org/drugbank_resource:3bd791e323b3beafbc6a893a9ca9c390> , <http://bio2rdf.org/drugbank_resource:80d05f76cbb76694ea904495c3f83347> , <http://bio2rdf.org/drugbank_resource:f4a43febd5a54c4918f01872054a5fb9> , <http://bio2rdf.org/drugbank_resource:ee02f096580d1140f2283235c4b55c78> , <http://bio2rdf.org/drugbank_resource:f3682897e4c20e6c4a84dea7e938c970> , <http://bio2rdf.org/drugbank_resource:fc307f5231f93b7e5949d1b89005df9d> , <http://bio2rdf.org/drugbank_resource:4bc998c1669fd3eb89c1373cac8c6655> , <http://bio2rdf.org/drugbank_resource:fb06a3920befd7b98ab29b2268c87737> ;
	<http://schema.org/clinicalPharmacology> "Used in the treatment of cystic fibrosis or pancreatic dysfunction, pancrelipase helps improve fat digestion in the small intestine. Specifically, the lipase, protease and amylase components break down fat, protein, and starches, respectively, in the small intestine. Lipase hydrolyzes fats into glycerol and fatty acids. Protease converts proteins into proteoses and derived substances, while amylase converts starches into dextrins and sugars. Pancreatic enzymes are used to correct maldigestion, malabsorption and pain associated with pancreatic insufficiency. The major maldigestion/malabsorption problems arise from incomplete fat digestion. Exogenous pancrelipase reduces the amount of nitrogen and fat excreted in the stool." ;
	<http://schema.org/cost> <http://bio2rdf.org/drugbank_resource:fabfd4bc6db7daec552d4d9d7680a1d5> , <http://bio2rdf.org/drugbank_resource:79ab2c1c7440c13241702076dd5d19ba> , <http://bio2rdf.org/drugbank_resource:1455dba056db65198be22dd7b9de91b5> , <http://bio2rdf.org/drugbank_resource:29908be8537ff75a79cf6833a461b15a> , <http://bio2rdf.org/drugbank_resource:b86002b41e7f14823116e1ce24323ba8> , <http://bio2rdf.org/drugbank_resource:a8c7cc5801792094f0055ebc2e9d3e21> , <http://bio2rdf.org/drugbank_resource:58cc0cb8d1b813d65f27ceb41a1fa2f1> , <http://bio2rdf.org/drugbank_resource:ad17eddaf3658ba5067de9988332c5d4> , <http://bio2rdf.org/drugbank_resource:db60df9a7361881c13b11f212f725c91> , <http://bio2rdf.org/drugbank_resource:c2716b6d823241ed07de0e8d9ba4c72e> , <http://bio2rdf.org/drugbank_resource:c491326d05c458e1d5bd46daab9acecd> , <http://bio2rdf.org/drugbank_resource:e1312af2dd2a5c8b01925d934d31add9> , <http://bio2rdf.org/drugbank_resource:c8e60da3d57e2298d631522fe49e6844> , <http://bio2rdf.org/drugbank_resource:022d47b05a48d7e1ed077af6a0f030ba> , <http://bio2rdf.org/drugbank_resource:409ff48fde8874d595ab2a22e4791904> , <http://bio2rdf.org/drugbank_resource:85656854a98a0017cedb7913b48928a9> , <http://bio2rdf.org/drugbank_resource:f500349aa6694ee3d7725b0d1d14e869> ;
	<http://schema.org/dosageForm> "Tablet" , "Injection, solution" , "Capsule, delayed release" , "Capsule, delayed release pellets" ;
	<http://schema.org/foodWarning> "Delayed release capsules should not be broken or crushed, but for those patients who cannot swallow the capsules, sprinkle the contents of the capsule onto soft acidic foods (pH of ≤4.5). Alkaline foods with a higher pH will promote early release of pancrelipase followed by enzyme inactivation in the stomach." ;
	<http://schema.org/legalStatus> "Approved" ;
	<http://schema.org/mechanismOfAction> "The lipase, protease and amylase components of pancrelipase break down fat, protein, and starches, respectively, in the small intestine. Lipase hydrolyzes fats into glycerol and fatty acids. Protease converts proteins into proteoses and derived substances, while amylase converts starches into dextrins and sugars." ;
	<http://schema.org/nonProprietaryName> "Pancreatic alpha-amylase precursor" , "1,4-alpha-D- glucan glucanohydrolase" , "PA" ;
	<http://schema.org/proprietaryName> "Cotazym" ;
	<http://schema.org/identifier> "drugbank:DB00085" ;
	<http://schema.org/sameAs> <http://www.rxlist.com/cgi/generic2/pancrel.htm> , <http://www.drugbank.ca/drugs/DB00085> , <http://www.drugs.com/cdi/amylase-lipase-protease.html> .

<http://bio2rdf.org/drugbank_resource:022d47b05a48d7e1ed077af6a0f030ba> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "3.0599999427795410156" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Ultrase MT 20 65-20-65mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:03e8c102c79db06eecd326f99a3b3942> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "17500; 4200; 10000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:06b122a4103620abd546ff8709085515> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "180000; 36000; 114000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release pellets form with oral route" .

<http://bio2rdf.org/drugbank_resource:1260467275068ce542e5c299b586399c> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "82000; 15000; 51000 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:1455dba056db65198be22dd7b9de91b5> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.75999999046325683594" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrease ec capsule" .

<http://bio2rdf.org/drugbank_resource:175732483eb5d0afdce1e0b87ee0ae6f> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "41400; 20700; 41400 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:27136092f71ea2dc0884122e1d472f2b> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "10 mg/mL Injection, solution form with epidural; infiltration route" .

<http://bio2rdf.org/drugbank_resource:29908be8537ff75a79cf6833a461b15a> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1.379999995231628418" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrelipase 10000 30-10-30mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:3bd791e323b3beafbc6a893a9ca9c390> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "78300; 20880; 78300 [USP'U]/1; [USP'U]/1; [USP'U] Tablet form with oral route" .

<http://bio2rdf.org/drugbank_resource:409ff48fde8874d595ab2a22e4791904> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1.6499999761581420898" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Ultrase MT 12 39-12-39mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:4bc998c1669fd3eb89c1373cac8c6655> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "30250; 8000; 28750 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:58cc0cb8d1b813d65f27ceb41a1fa2f1> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.63999998569488525391" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrelipase ec 4500 capsule" .

<http://bio2rdf.org/drugbank_resource:5ebc91afa2630a7ae33f0c165c59a6e5> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "43750; 10500; 25000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:5ec480f1898bc210cd4f4f879582cacb> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "218000; 40000; 136000 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:79ab2c1c7440c13241702076dd5d19ba> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "2.8299999237060546875" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Creon 20 66.4-20-75mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:80d05f76cbb76694ea904495c3f83347> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "15125; 4000; 14375 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:8532faf6b74a0718755250462da33523> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "39150; 10440; 39150 [USP'U]/1; [USP'U]/1; [USP'U] Tablet form with oral route" .

<http://bio2rdf.org/drugbank_resource:85656854a98a0017cedb7913b48928a9> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1.0299999713897705078" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrelipase MST-16 48-16-48mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:9a3b4abb8f273fa2f383b551a1894f0f> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "136000; 25000; 85000 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:a8c7cc5801792094f0055ebc2e9d3e21> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.87000000476837158203" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrease 4500 unit Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:ac19273ac22375d315e23710d2b5cc80> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "60500; 16000; 57500 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:ad17eddaf3658ba5067de9988332c5d4> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "3.3199999332427978516" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Creon 24000 unit Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:b249bfa106599ab2ea815c0538721b01> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "70000; 16800; 40000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:b36bd6c496a004338641872653e73c55> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "120000; 24000; 76000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release pellets form with oral route" .

<http://bio2rdf.org/drugbank_resource:b86002b41e7f14823116e1ce24323ba8> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "2.9900000095367431641" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrease MT 20 56-20-44mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:ba17e8c73ecc076468a27be60bd51000> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "16000; 3000; 10000 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:bfa1b3202d38637a18d8bcfd8c3e23e1> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "60000; 12000; 38000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release pellets form with oral route" .

<http://bio2rdf.org/drugbank_resource:c2716b6d823241ed07de0e8d9ba4c72e> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1.4900000095367431641" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrease MT 10 30-10-30mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:c491326d05c458e1d5bd46daab9acecd> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.80000001192092895508" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Ultrase 4500 unit Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:c78b0a07c1f0add4a6a69d96c1a51410> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "30000; 6000; 19000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release pellets form with oral route" .

<http://bio2rdf.org/drugbank_resource:c8e60da3d57e2298d631522fe49e6844> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "0.86000001430511474609" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Creon 5 16.6-5-18.75mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:d7b4a2cd91ffa76e6ced42d860f720e6> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "27600; 13800; 27600 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:d9ffd5f12f88be5848c77072a4dc4885> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "27000; 5000; 17000 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:db60df9a7361881c13b11f212f725c91> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "2.0199999809265136719" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrelipase 16000 48-16-48mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:e1312af2dd2a5c8b01925d934d31add9> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1.5399999618530273438" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Creon 10 33.2-10-37.5mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:e42f8d5be9f3d3dd82e7435e76128245> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "20 mg/mL Injection, solution form with epidural; infiltration route" .

<http://bio2rdf.org/drugbank_resource:e683fe8ebafdf4d83c824776e4144db6> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "55000; 10000; 34000 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:ee02f096580d1140f2283235c4b55c78> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "61000; 21000; 37000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:f3682897e4c20e6c4a84dea7e938c970> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "109000; 20000; 68000 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:f4a43febd5a54c4918f01872054a5fb9> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "15000; 3000; 9500 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:f500349aa6694ee3d7725b0d1d14e869> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "2.6500000953674316406" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Ultrase MT 18 58.5-18-58.5mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:f70279cb9494a9eda450c00b55d0352f> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "46000; 23000; 46000 [USP&apos'U]/1; [USP&apos'U]/1; [USP&apos'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:fabfd4bc6db7daec552d4d9d7680a1d5> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "2.4000000953674316406" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Pancrease MT 16 48-16-48mu Enteric Coated Capsule" .

<http://bio2rdf.org/drugbank_resource:fb06a3920befd7b98ab29b2268c87737> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "27000; 5000; 17000 [USP'U]/1; [USP'U]/1; [USP'U] Capsule, delayed release form with oral route" .

<http://bio2rdf.org/drugbank_resource:fc307f5231f93b7e5949d1b89005df9d> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "15 mg/mL Injection, solution form with epidural; infiltration route" .
